Go to deals
Healthcare

Prevtec Microbia has raised an undisclosed amount

Prevtec Microbia has raised an undisclosed amount.

Prevtec Microbia is a Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in animal foods, improve animal health and increase animal production performance. It is an innovation-centric company that operates in many areas through strategic alliances around the world.

Oaklins’ team in Montreal, Canada, advised Prevtec Microbia in the transaction.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Fausto  Levy

Fausto Levy

Principal
Montreal, Canada
Oaklins E. Canada

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Laboratoire Dazont has been acquired by SBM Company
Healthcare

Laboratoire Dazont has been acquired by SBM Company

The shareholders of Laboratoire Dazont have sold the company to SBM Company.

Learn more
Monument MicroCap Partners has sold Montgomery DME to Incline Equity Partners
Private Equity | Healthcare

Monument MicroCap Partners has sold Montgomery DME to Incline Equity Partners

Monument MicroCap Partners, LLC (MMP) has sold Montgomery DME (MDME) to Incline Equity Partners.

Learn more